PHI News Room
All News and Press Releases
Enter any phrase or word you would like to search for and click .
PostNews: Press Release
PHI’s Board of Directors proposes signing Altium as global distributor partner
PHI’s Board of Directors decided to propose signing Altium S.A., which also is the Company’s largest shareholder, as a global PHI distributor partner.
PostNews: Press Release
PHI’s Board of Directors proposes a Direct Issue of shares of 9.9 MSEK to Altium
PHI’s Board of Directors proposes a direct issue of 2 374 820 new shares to the Company’s largest shareholder, Altium S.A.
PostNews: Press Release
PHI endorses WFIRM as Finalist for NSF’s $160 Million Innovation Grant
PHI proudly stands behind the Wake Forest Institute for Regenerative Medicine (WFIRM) as they contend as a finalist in the National Science Foundation’s (NSF) Regional Innovation Engines competition, with a potential award of up to $160 million.
PostNews: Press Release
Notice of Annual General Meeting in Phase Holographic Imaging PHI AB
The shareholders of Phase Holographic Imaging PHI AB (publ), 556542-7811, are hereby invited to the annual general meeting on Friday 27 October 2023 at 13.00 at Scandic Star Hotel, Glimmervägen 5 in Lund.
PostNews: Interim Report
Interim Report 1 2023/24
During this past summer quarter, we made it our most prosperous Q1 quarter to date, characterized by sustained growth.
PostNews: Press Release
Notice that Interim Report 1 2023/24 will be published on September 20, 2023
Phase Holographic Imaging announces that the date for publication of Interim Report 1 2023/24 is September 20, 2023.
Company News
Here, you see PHI featured in recent news and find previous CEO commentaries.
Fighting cancer with nanoparticles
Using HoloMonitor, scientists at Northeastern University have shown that paclitaxel-resistant ovarian cancer cells stopped multiplying by cell division when treated with nanoparticles. Ovarian cancer causes more deaths than any other cancer of the female reproductive system.
No Blood, No Tumor
Scientists at Boston Children’s Hospital have used HoloMonitor to study living bone cancer cells. By studying their dynamics, they have successfully for the first time distinguished aggressive bone cancer cells that promote blood vessel formation from the harmless counterparts that do not promote blood vessel formation.
Big Data, Fewer Cells
Scientists at Holographic Imaging Cytometry Program of Excellence at Northeastern University have developed a method to compare time series data of drug treated cells with untreated cells.
3D Culture
Using HoloMonitor and a public domain image processing software called Image J, the researchers from Northeastern University have developed a method for cell experiments based on cells cultured in a 3-dimensional collagen gel. They show that this new method is clearly superior to conventional methods, based on cells cultured on a 2-dimensional.
